Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Filgrastim × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Myelodysplastic Syndromes 15 Hodgkin Disease 11 Lymphoma, Non-Hodgkin 10 Lymphoma 8 Leukemia, Biphenotypic, Acute 8 Leukemia 8 Lymphoma, Large B-Cell, Diffuse 7 Burkitt Lymphoma 7 Breast Neoplasms 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Hematologic Neoplasms 5 Neoplasms 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelomonocytic, Chronic 4 Anemia, Refractory, with Excess of Blasts 4 Triple Negative Breast Neoplasms 3 Rhabdomyosarcoma 3 Medulloblastoma 3 Lymphoma, Follicular 3 Recurrence 2 Neuroblastoma 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, AIDS-Related 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myelomonocytic, Acute 2

Interventions

Cyclophosphamide 11 blinatumomab 8 fludarabine 7 venetoclax 6 fludarabine phosphate 5 Cytarabine 5 Rituximab 4 Lenalidomide 4 Dexamethasone 4 Blood Specimen Collection 4 Azacitidine 4 obinutuzumab 3 daratumumab 3 pembrolizumab 2 nilotinib 2 Vincristine 2 Radiotherapy 2 Methotrexate 2 Melphalan 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Idarubicin 2 Daunorubicin 2 Dasatinib 2 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡